Andreas Merz, PhD, currently serves as the Director, Portfolio Leader, and Franchise Lead for Hematology at Roche since October 2015, overseeing a comprehensive hematology portfolio and guiding key investment decisions. With prior experience at The Janssen Pharmaceutical Companies of Johnson & Johnson, Andreas held various roles that included EMEA Business Insights Manager and Business Insights Manager for Infectious Diseases, focusing on market dynamics and strategic insights. Earlier positions include Senior Strategy Consultant at NOVUMED Life Science Consulting & Advisory and Scientist at the University of Heidelberg, where Andreas conducted significant research on Hepatitis C virus pathogenesis. Andreas holds a PhD in Virology and Molecular Cell Biology from Heidelberg University and has a Master of Science equivalent in Molecular Biology from Ulm University, complemented by training in pharmaceutical forecasting. Recognized for exceptional contributions, Andreas received multiple awards, including the Roche Award of Excellence in 2019.
This person is not in the org chart
This person is not in any teams
This person is not in any offices